FDA Inspection 1323306 — Entrogen, Inc
The FDA completed an inspection of Entrogen, Inc on May 14, 2026 in Woodland Hills, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 14, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Woodland Hills, CA (United States)